nach oben

Clinical Research in Cardiology

Erschienen in:

01.09.2015 | Review

The importance of sleep-disordered breathing in cardiovascular disease

verfasst von: Dominik Linz, Holger Woehrle, Thomas Bitter, Henrik Fox, Martin R. Cowie, Michael Böhm, Olaf Oldenburg

Erschienen in: Clinical Research in Cardiology | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Obstructive sleep apnoea and central sleep apnoea/Cheyne-Stokes respiration are collectively referred to as sleep-disordered breathing (SDB). Rapidly accumulating evidence suggests that both forms of SDB, and often a combination of both, are highly prevalent in patients with a wide variety of cardiovascular diseases, including hypertension, heart failure, arrhythmias, coronary artery disease, acute coronary syndrome and stroke. The presence of SDB in these patients is independently associated with worse cardiac function and exercise tolerance, recurrent arrhythmias, infarct expansion, decreased quality of life and increased mortality. Recent data suggest positive effects of positive airway pressure (PAP) therapy on quality of life and cardiovascular function. In addition, ongoing clinical trials may soon provide first definitive data on PAP therapy of SDB on hard outcomes such as mortality. This review presents current data highlighting links between SDB and a variety of cardiovascular conditions, the importance of recognising and diagnosing SDB in patients with cardiovascular disease, and the effects of effective SDB treatment on cardiovascular endpoints.

Gami AS, Somers VK (2008) Implications of obstructive sleep apnea for atrial fibrillation and sudden cardiac death. J Cardiovasc Electrophysiol 19(9):997–1003PubMed

Hillman DR, Murphy AS, Pezzullo L (2006) The economic cost of sleep disorders. Sleep 29(3):299–305PubMed

Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed

Leger D, Bayon V, Laaban JP, Philip P (2012) Impact of sleep apnea on economics. Sleep Med Rev 16(5):455–462PubMed

Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS, Bradley TD (2001) High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19(12):2271–2277PubMed

Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B (1999) Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 92(2):79–84PubMed

Stevenson IH, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman JM (2008) Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J 29:1662–1669PubMed

Gilmartin GS, Daly RW, Thomas RJ (2005) Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med 11(6):485–493PubMed

Won C, Guilleminault C (2015) Gender differences in sleep disordered breathing: implications for therapy. Expert Rev Respir Med 9(2):221–231PubMed

10.

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 52(8):686–717PubMed

11.

Bitter T, Westerheide N, Hossain SM, Prinz C, Horstkotte D, Oldenburg O (2012) Symptoms of sleep apnoea in chronic heart failure–results from a prospective cohort study in 1,500 patients. Sleep Breath 16(3):781–791PubMed

12.

Sullivan CE, Issa FG, Berthon-Jones M, Eves L (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1(8225):862–865PubMed

13.

Lenique F, Habis M, Lofaso F, Dubois-Rande JL, Harf A, Brochard L (1997) Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med 155(2):500–505PubMed

14.

Naughton MT, Rahman MA, Hara K, Floras JS, Bradley TD (1995) Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91(6):1725–1731PubMed

15.

McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ (1999) Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159(4 Pt 1):1108–1114PubMed

16.

Gindre L, Gagnadoux F, Meslier N, Gustin JM, Racineux JL (2008) Mandibular advancement for obstructive sleep apnea: dose effect on apnea, long-term use and tolerance. Respiration 76(4):386–392PubMed

17.

Lam B, Sam K, Lam JC, Lai AY, Lam CL, Ip MS (2011) The efficacy of oral appliances in the treatment of severe obstructive sleep apnea. Sleep Breath 15(2):195–201PubMed

18.

Oldenburg O (2012) Cheyne-stokes respiration in chronic heart failure. Treatment with adaptive servoventilation therapy. Circ J 76(10):2305–2317PubMed

19.

Eckert DJ, Jordan AS, Merchia P, Malhotra A (2007) Central sleep apnea: pathophysiology and treatment. Chest 131(2):595–607PubMedCentralPubMed

20.

Arzt M, Harth M, Luchner A, Muders F, Holmer SR, Blumberg FC, Riegger GA, Pfeifer M (2003) Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 107(15):1998–2003PubMed

21.

Jelic S, Le Jemtel TH (2009) Sleep-disordered breathing in acute decompensated heart failure. Curr Heart Fail Rep 6(3):169–175PubMed

22.

Wedewardt J, Bitter T, Prinz C, Faber L, Horstkotte D, Oldenburg O (2010) Cheyne-Stokes respiration in heart failure: cycle length is dependent on left ventricular ejection fraction. Sleep Med 11(2):137–142PubMed

23.

Oldenburg O, Spiesshofer J, Fox H, Bitter T, Horstkotte D (2015) Cheyne-Stokes respiration in heart failure: friend or foe? Hemodynamic effects of hyperventilation in heart failure patients and healthy volunteers. Clin Res Cardiol 104(4):328–333PubMed

24.

Fox H, Puehler T, Schulz U, Bitter T, Horstkotte D, Oldenburg O (2014) Delayed recovery from Cheyne-Stokes respiration in heart failure after successful cardiac transplantation: a case report. Transplant Proc 46(7):2462–2463PubMed

25.

Kohnlein T, Welte T (2007) Does beta-blocker treatment influence central sleep apnoea? Respir Med 101(4):850–853PubMed

26.

Oldenburg O, Faber L, Vogt J, Dorszewski A, Szabados F, Horstkotte D, Lamp B (2007) Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 9(8):820–826PubMed

27.

Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J (2007) Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 131(1):130–135PubMed

28.

Arzt M, Bradley TD (2006) Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 173(12):1300–1308PubMed

29.

Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T (1999) Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159(5 Pt 1):1490–1498PubMed

30.

Su MC, Chiu KL, Ruttanaumpawan P, Shiota S, Yumino D, Redolfi S, Haight JS, Bradley TD (2008) Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol 161(3):306–312PubMed

31.

Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99(12):1574–1579PubMed

32.

Bradley TD, Floras JS (2003) Sleep apnea and heart failure: part II: central sleep apnea. Circulation 107(13):1822–1826PubMed

33.

Bitter T, Westerheide N, Hossain MS, Lehmann R, Prinz C, Kleemeyer A, Horstkotte D, Oldenburg O (2011) Complex sleep apnoea in congestive heart failure. Thorax 66(5):402–407PubMed

34.

Morgenthaler TI, Kuzniar TJ, Wolfe LF, Willes L, McLain WC 3rd, Goldberg R (2014) The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy. Sleep 37(5):927–934PubMedCentralPubMed

35.

Teschler H, Dohring J, Wang YM, Berthon-Jones M (2001) Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164(4):614–619PubMed

36.

Johnson KG, Johnson DC (2005) Bilevel positive airway pressure worsens central apneas during sleep. Chest 128(4):2141–2150PubMed

37.

Aurora RN, Chowdhuri S, Ramar K, Bista SR, Casey KR, Lamm CI, Kristo DA, Mallea JM, Rowley JA, Zak RS, Tracy SL (2012) The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35(1):17–40PubMedCentralPubMed

38.

Oldenburg O, Spiesshofer J, Fox H, Prib N, Horstkotte D (2014) Performance of conventional and enhanced adaptive servoventilation (ASV) in heart failure patients with central sleep apnea who have adapted to conventional ASV. Sleep Breath. doi:10.1007/s11325-014-1083-9

39.

Abraham WT, Jagielski D, Oldenburg O, Augostini R, Krueger S, Kolodziej A, Gutleben KJ, Khayat R, Merliss A, Harsch MR, Holcomb RG, Javaheri S, Ponikowski P (2015) Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Failure. doi:10.1016/j.jchf.2014.12.013

40.

Oldenburg O, Bitter T, Fox H, Horstkotte D, Gutleben KJ (2014) Effects of unilateral phrenic nerve stimulation on tidal volume. First case report of a patient responding to remede(R) treatment for nocturnal Cheyne-Stokes respiration. Herz 39(1):84–86PubMed

41.

Ponikowski P, Javaheri S, Michalkiewicz D, Bart BA, Czarnecka D, Jastrzebski M, Kusiak A, Augostini R, Jagielski D, Witkowski T, Khayat RN, Oldenburg O, Gutleben KJ, Bitter T, Karim R, Iber C, Hasan A, Hibler K, Germany R, Abraham WT (2012) Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure. Eur Heart J 33(7):889–894PubMedCentralPubMed

42.

Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96(4):1897–1904PubMedCentralPubMed

43.

Koshino Y, Villarraga HR, Orban M, Bruce CJ, Pressman GS, Leinveber P, Saleh HK, Konecny T, Kara T, Somers VK, Lopez-Jimenez F (2010) Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults: a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea. Circ Cardiovasc Imaging 3(3):282–289PubMed

44.

Levy P, Ryan S, Oldenburg O, Parati G (2013) Sleep apnoea and the heart. Eur Respir Rev 22(129):333–352PubMed

45.

Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276PubMed

46.

Javaheri S, Shukla R, Zeigler H, Wexler L (2007) Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 49(20):2028–2034PubMed

47.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C (2003) The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560–2572PubMed

48.

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O’Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, Management of Arterial Hypertension of the European Society of H, European Society of C (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25(6):1105–1187PubMed

49.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryden L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219PubMed

50.

Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD (2003) Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21(2):241–247PubMed

51.

Pedrosa RP, Drager LF, de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G (2013) Effects of obstructive sleep apnea treatment on blood pressure in patients with resistant hypertension: a randomized trial. Chest 144(5):1487–1494PubMed

52.

Guillot M, Sforza E, Achour-Crawford E, Maudoux D, Saint-Martin M, Barthelemy JC, Roche F (2013) Association between severe obstructive sleep apnea and incident arterial hypertension in the older people population. Sleep Med 14(9):838–842PubMed

53.

Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M (2008) Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 31(6):795–800PubMedCentralPubMed

54.

Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J (1994) Sleep apnea and hypertension. A population-based study. Ann Intern Med 120(5):382–388PubMed

55.

Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320(7233):479–482PubMedCentralPubMed

56.

Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, Barbe F, Vicente E, Wei Y, Nieto FJ, Jelic S (2012) Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 307(20):2169–2176PubMed

57.

Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283(14):1829–1836PubMed

58.

Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384PubMed

59.

Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J (1997) Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157(15):1746–1752PubMed

60.

Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, Tracy RP, Rueschman M, Blumenthal RS, Lewis EF, Bhatt DL, Redline S (2014) CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 370(24):2276–2285PubMedCentralPubMed

61.

Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ, Bohm M (2014) Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 27(10):1293–1300PubMed

62.

Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Levy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT, European Respiratory S, members ECAB (2012) Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 30(4):633–646PubMed

63.

Bazzano LA, Khan Z, Reynolds K, He J (2007) Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50(2):417–423PubMed

64.

Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, Velkeniers B (2007) The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167(8):757–764PubMed

65.

Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, Peter JH (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73PubMed

66.

Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR (2006) Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27(6):1229–1235PubMed

67.

Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, Narkiewicz K, Minuz P (2014) Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest 145(4):762–771PubMed

68.

Lozano L, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, Espinel E, Rios J, Untoria MD, Lloberes P (2010) Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 28(10):2161–2168PubMed

69.

Martinez-Garcia MA, Capote F, Campos-Rodriguez F, Lloberes P, Diaz de Atauri J, Somoza M, Masa JF, Gonzalez M, Sacristan L, Barbe F, Duran-Cantolla J, Aizpuru F, Manas E, Barreiro B, Mosteiro M, Cebrian JJ, de la Pena M, Garcia-Rio F, Maimo A, Zapater J, Hernandez C, SanMarti NG, Montserrat JM, Network Spanish Sleep (2013) Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension. The HIPARCO Randomized clinical trial. JAMA 310(22):2407–2415PubMed

70.

Middleton S, Vermeulen W, Byth K, Sullivan CE, Middleton PG (2009) Treatment of obstructive sleep apnoea in Samoa progressively reduces daytime blood pressure over 6 months. Respirology 14(3):404–410PubMed

71.

Pepin JL, Tamisier R, Barone-Rochette G, Launois SH, Levy P, Baguet JP (2010) Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 182(7):954–960PubMed

72.

Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G (2011) Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58(5):811–817PubMed

73.

Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM (2008) Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51(6):1403–1419PubMed

74.

Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O’Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMed

75.

Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT, Punjabi NM, Quan SF, Redline S, Resnick HE, Tong EK, Diener-West M, Shahar E (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122(4):352–360PubMedCentralPubMed

76.

Bitter T, Langer C, Vogt J, Lange M, Horstkotte D, Oldenburg O (2009) Sleep-disordered breathing in patients with atrial fibrillation and normal systolic left ventricular function. Dtsch Arztebl Int 106(10):164–170PubMedCentralPubMed

77.

Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257PubMed

78.

Herrscher TE, Akre H, Overland B, Sandvik L, Westheim AS (2011) High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 17(5):420–425PubMed

79.

Noda A, Miyata S, Yasuda Y (2013) Therapeutic strategies for sleep apnea in hypertension and heart failure. Pulm Med 2013:814169PubMedCentralPubMed

80.

Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, Arzt M (2011) Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 13(1):68–75PubMed

81.

Khayat R, Abraham W, Patt B, Brinkman V, Wannemacher J, Porter K, Jarjoura D (2012) Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. J Card Fail 18(7):534–540PubMedCentralPubMed

82.

Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, Ruttanaumpawan P, Tomlinson G, Bradley TD (2007) Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49(15):1625–1631PubMed

83.

Brack T, Thuer I, Clarenbach CF, Senn O, Noll G, Russi EW, Bloch KE (2007) Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 132(5):1463–1471PubMed

84.

Damy T, Margarit L, Noroc A, Bodez D, Guendouz S, Boyer L, Drouot X, Lamine A, Paulino A, Rappeneau S, Stoica MH, Dubois-Rande JL, Adnot S, Hittinger L, d’Ortho MP (2012) Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail 14(9):1009–1019PubMed

85.

Arzt M, Young T, Finn L, Skatrud JB, Ryan CM, Newton GE, Mak S, Parker JD, Floras JS, Bradley TD (2006) Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 166(16):1716–1722PubMed

86.

Wang X, Ouyang Y, Wang Z, Zhao G, Liu L, Bi Y (2013) Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies. Int J Cardiol 169(3):207–214PubMed

87.

Aggarwal A, Esler MD, Lambert GW, Hastings J, Johnston L, Kaye DM (2002) Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation 105(9):1031–1033PubMed

88.

Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMed

89.

Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169(3):361–366PubMed

90.

Kasai T, Narui K, Dohi T, Yanagisawa N, Ishiwata S, Ohno M, Yamaguchi T, Momomura S (2008) Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133(3):690–696PubMed

91.

Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J (2005) Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 112(3):375–383PubMed

92.

Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN, Heart Failure Society of America (2010) HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 16(6):e1-194PubMed

93.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(16):e147–e239PubMed

94.

Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102(1):61–66PubMed

95.

Takasaki Y, Orr D, Popkin J, Rutherford R, Liu P, Bradley TD (1989) Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure. Am Rev Respir Dis 140(6):1578–1584PubMed

96.

Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353(19):2025–2033PubMed

97.

Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Ryan C, Tomlinson G, Bradley TD (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115(25):3173–3180PubMed

98.

Monahan K, Redline S (2011) Role of obstructive sleep apnea in cardiovascular disease. Curr Opin Cardiol 26(6):541–547PubMedCentralPubMed

99.

Hastings PC, Vazir A, Meadows GE, Dayer M, Poole-Wilson PA, McIntyre HF, Morrell MJ, Cowie MR, Simonds AK (2010) Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol 139(1):17–24PubMed

100.

Koyama T, Watanabe H, Igarashi G, Terada S, Makabe S, Ito H (2011) Short-term prognosis of adaptive servo-ventilation therapy in patients with heart failure. Circ J 75(3):710–712PubMed

101.

Schadlich S, Konigs I, Kalbitz F, Blankenburg T, Busse HJ, Schutte W (2004) Cardiac efficiency in patients with Cheyne-Stokes respiration as a result of heart insufficiency during long-term nasal respiratory treatment with adaptive servo ventilation (AutoSet CS). Z Kardiol 93(6):454–462PubMed

102.

Takama N, Kurabayashi M (2011) Effectiveness of adaptive servo-ventilation for treating heart failure regardless of the severity of sleep-disordered breathing. Circ J 75(5):1164–1169PubMed

103.

Topfer V, El-Sebai M, Wessendorf TE, Moraidis I, Teschler H (2004) Adaptive servoventilation: effect on Cheyne-Stokes-respiration and on quality of life. Pneumologie 58(1):28–32PubMed

104.

Zhang XL, Yin KS, Li XL, Jia EZ, Su M (2006) Efficacy of adaptive servoventilation in patients with congestive heart failure and Cheyne-Stokes respiration. Chin Med J (Engl) 119(8):622–627

105.

Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A (2012) Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 142(5):1211–1221PubMedCentralPubMed

106.

Campbell AJ, Ferrier K, Neill AM (2012) Effect of oxygen versus adaptive pressure support servo-ventilation in patients with central sleep apnoea-Cheyne Stokes respiration and congestive heart failure. Intern Med J 42(10):1130–1136PubMed

107.

Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, Yamaguchi T, Yamashina A, Momomura SI, Investigators J (2010) Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail 3(1):140–148PubMed

108.

Kourouklis SP, Vagiakis E, Paraskevaidis IA, Farmakis D, Kostikas K, Parissis JT, Katsivas A, Kremastinos DT, Anastasiou-Nana M, Filippatos G (2013) Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure. Int J Cardiol 168(1):157–162PubMed

109.

Miyata M, Yoshihisa A, Suzuki S, Yamada S, Kamioka M, Kamiyama Y, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2012) Adaptive servo ventilation improves Cheyne-Stokes respiration, cardiac function, and prognosis in chronic heart failure patients with cardiac resynchronization therapy. J Cardiol 60(3):222–227PubMed

110.

Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies RJ (2003) A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 168(9):1109–1114PubMed

111.

Randerath WJ, Nothofer G, Priegnitz C, Anduleit N, Treml M, Kehl V, Galetke W (2012) Long-term auto-servoventilation or constant positive pressure in heart failure and coexisting central with obstructive sleep apnea. Chest 142(2):440–447PubMed

112.

Arzt M, Schroll S, Series F, Lewis K, Benjamin A, Escourrou P, Luigart R, Kehl V, Pfeifer M (2013) Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial. Eur Respir J 42(5):1244–1254PubMed

113.

Birner C, Series F, Lewis K, Benjamin A, Wunderlich S, Escourrou P, Zeman F, Luigart R, Pfeifer M, Arzt M (2014) Effects of auto-servo ventilation on patients with sleep-disordered breathing, stable systolic heart failure and concomitant diastolic dysfunction: subanalysis of a randomized controlled trial. Respiration 87(1):54–62PubMed

114.

Fietze I, Blau A, Glos M, Theres H, Baumann G, Penzel T (2008) Bi-level positive pressure ventilation and adaptive servo ventilation in patients with heart failure and Cheyne-Stokes respiration. Sleep Med 9(6):652–659PubMed

115.

Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, Michel PL, Rouault S, d’Ortho MP (2006) Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92(3):337–342PubMedCentralPubMed

116.

Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’Ortho MP, Erdmann E, Levy P, Simonds A, Somers VK, Zannad F, Teschler H (2013) Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure. Eur J Heart Fail 15(8):937–943PubMedCentralPubMed

117.

Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, Horstkotte D, Oldenburg O (2010) Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J 36(2):385–392PubMed

118.

Yoshihisa A, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S, Takeishi Y (2013) Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing. Eur J Heart Fail 15(5):543–550PubMed

119.

Bordier P, Maurice-Tison S, Ramana NK (2012) Overdrive ventricular pacing in pacemaker recipients with permanent atrial fibrillation and sleep apnea. J Clin Sleep Med 8(3):257–264PubMedCentralPubMed

120.

Hohl M, Linz B, Bohm M, Linz D (2014) Obstructive sleep apnea and atrial arrhythmogenesis. Curr Cardiol Rev 10(4):362–368PubMed

121.

Linz D, Hohl M, Ukena C, Mahfoud F, Wirth K, Neuberger HR, Bohm M (2015) Obstructive respiratory events and premature atrial contractions after cardioversion. Eur Respir J. doi:10.1183/09031936.00175714 PubMed

122.

Linz D, Schotten U, Neuberger HR, Bohm M, Wirth K (2011) Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 8(9):1436–1443PubMed

123.

Iwasaki YK, Kato T, Xiong F, Shi YF, Naud P, Maguy A, Mizuno K, Tardif JC, Comtois P, Nattel S (2014) Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64(19):2013–2023PubMed

124.

Monahan K, Brewster J, Wang L, Parvez B, Goyal S, Roden DM, Darbar D (2012) Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 110(3):369–372PubMedCentralPubMed

125.

Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, Shamsuzzaman AS, Somers VK (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20):2589–2594PubMed

126.

Ng CY, Liu T, Shehata M, Stevens S, Chugh SS, Wang X (2011) Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 108(1):47–51PubMed

127.

Patel D, Mohanty P, Di Biase L, Shaheen M, Lewis WR, Quan K, Cummings JE, Wang P, Al-Ahmad A, Venkatraman P, Nashawati E, Lakkireddy D, Schweikert R, Horton R, Sanchez J, Gallinghouse J, Hao S, Beheiry S, Cardinal DS, Zagrodzky J, Canby R, Bailey S, Burkhardt JD, Natale A (2010) Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol 3(5):445–451PubMed

128.

Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E (2013) Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 62(4):300–305PubMed

129.

Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Jr., Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on C, Surgical Ablation of Atrial F (2012) 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 9(4):632–696 e621

130.

Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, Herges RM, Howard DE, Somers VK (2013) Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal Study of 10,701 adults. J Am Coll Cardiol 62(7):610–616PubMed

131.

Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, Horstkotte D, Oldenburg O (2011) Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 32(1):61–74PubMed

132.

Gami AS, Howard DE, Olson EJ, Somers VK (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352(12):1206–1214PubMed

133.

Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 173(8):910–916PubMedCentralPubMed

134.

Monahan K, Storfer-Isser A, Mehra R, Shahar E, Mittleman M, Rottman J, Punjabi N, Sanders M, Quan SF, Resnick H, Redline S (2009) Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 54(19):1797–1804PubMedCentralPubMed

135.

Bitter T, Gutleben KJ, Nolker G, Westerheide N, Prinz C, Dimitriadis Z, Horstkotte D, Vogt J, Oldenburg O (2013) Treatment of cheyne-stokes respiration reduces arrhythmic events in chronic heart failure. J Cardiovasc Electrophysiol 24(10):1132–1140PubMed

136.

Andreas S, Schulz R, Werner GS, Kreuzer H (1996) Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 7(7):541–545PubMed

137.

Danzi-Soares NJ, Genta PR, Nerbass FB, Pedrosa RP, Soares FS, Cesar LA, Drager LF, Skomro R, Lorenzi-Filho G (2012) Obstructive sleep apnea is common among patients referred for coronary artery bypass grafting and can be diagnosed by portable monitoring. Coron Artery Dis 23(1):31–38PubMed

138.

Lee CH, Khoo SM, Tai BC, Chong EY, Lau C, Than Y, Shi DX, Lee LC, Kailasam A, Low AF, Teo SG, Tan HC (2009) Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion. Chest 135(6):1488–1495PubMed

139.

Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P (1996) Sleep-disordered breathing in men with coronary artery disease. Chest 109(3):659–663PubMed

140.

Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P (1996) Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 101(3):251–256PubMed

141.

Nakashima H, Katayama T, Takagi C, Amenomori K, Ishizaki M, Honda Y, Suzuki S (2006) Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 27(19):2317–2322PubMed

142.

Glantz H, Thunstrom E, Herlitz J, Cederin B, Nasic S, Ejdeback J, Peker Y (2013) Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort. Ann Am Thorac Soc 10(4):350–356PubMed

143.

Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28(3):596–602PubMed

144.

Sharma S, Gebregziabher M, Parker AT, Abro JA, Armstrong AM, Schoepf UJ (2012) Independent association between obstructive sleep apnea and noncalcified coronary plaque demonstrated by noninvasive coronary computed tomography angiography. Clin Cardiol 35(10):641–645PubMed

145.

Hanly P, Sasson Z, Zuberi N, Lunn K (1993) ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71(15):1341–1345PubMed

146.

Mooe T, Franklin KA, Holmstrom K, Rabben T, Wiklund U (2001) Sleep-disordered breathing and coronary artery disease. Long-term prognosis. Am J Respir Crit Care Med 164(10):1910–1913PubMed

147.

Konecny T, Kuniyoshi FH, Orban M, Pressman GS, Kara T, Gami A, Caples SM, Lopez-Jimenez F, Somers VK (2010) Under-diagnosis of sleep apnea in patients after acute myocardial infarction. J Am Coll Cardiol 56(9):742–743PubMedCentralPubMed

148.

Buchner S, Greimel T, Hetzenecker A, Luchner A, Hamer OW, Debl K, Poschenrieder F, Fellner C, Riegger GA, Pfeifer M, Arzt M (2012) Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J 40(5):1173–1179PubMed

149.

Buchner S, Satzl A, Debl K, Hetzenecker A, Luchner A, Husser O, Hamer OW, Poschenrieder F, Fellner C, Zeman F, Riegger GA, Pfeifer M, Arzt M (2013) Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction. Eur Heart J 35(3):192–199PubMed

150.

Correia LC, Souza AC, Garcia G, Sabino M, Brito M, Maraux M, Rabelo MM, Esteves JP (2012) Obstructive sleep apnea affects hospital outcomes of patients with non-ST-elevation acute coronary syndromes. Sleep 35(9):1241A–1245A

151.

Peker Y, Hedner J, Kraiczi H, Loth S (2000) Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162(1):81–86PubMed

152.

Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H (2007) Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99(1):26–30PubMed

153.

Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A (2007) Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 50(14):1310–1314PubMed

154.

Garcia-Rio F, Alonso-Fernandez A, Armada E, Mediano O, Lores V, Rojo B, Fernandez-Lahera J, Fernandez-Navarro I, Carpio C, Ramirez T (2013) CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol 168(2):1328–1335PubMed

155.

Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMed

156.

Milleron O, Pilliere R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G, Raffestin BG, Dubourg O (2004) Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25(9):728–734PubMed

157.

Esquinas C, Sanchez-de-la Torre M, Aldoma A, Flores M, Martinez M, Barcelo A, Barbe F, Spanish Sleep N (2013) Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: the ISAACC Trial. Clin Cardiol 36(9):495–501PubMed

158.

Ohira T, Tanigawa T, Tabata M, Imano H, Kitamura A, Kiyama M, Sato S, Okamura T, Cui R, Koike KA, Shimamoto T, Iso H (2009) Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension 53(1):13–19PubMed

159.

Scanlan MF, Roebuck T, Little PJ, Redman JR, Naughton MT (2000) Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 16(5):909–913PubMed

160.

Taasan VC, Block AJ, Boysen PG, Wynne JW (1981) Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med 71(2):240–245PubMed

161.

Mitler MM, Dawson A, Henriksen SJ, Sobers M, Bloom FE (1988) Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 12(6):801–805PubMedCentralPubMed

162.

Young T, Peppard PE, Taheri S (2005) Excess weight and sleep-disordered breathing. J Appl Physiol 99(4):1592–1599PubMed

163.

Araghi MH, Chen YF, Jagielski A, Choudhury S, Banerjee D, Hussain S, Thomas GN, Taheri S (2013) Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep 36(10):1553–1562 1562A–1562E PubMedCentralPubMed

164.

Ashrafian H, Toma T, Rowland SP, Harling L, Tan A, Efthimiou E, Darzi A, Athanasiou T (2014) Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg. doi:10.1007/s11695-014-1533-2 PubMed

165.

Abed HS, Wittert GA, Leong DP, Shirazi MG, Bahrami B, Middeldorp ME, Lorimer MF, Lau DH, Antic NA, Brooks AG, Abhayaratna WP, Kalman JM, Sanders P (2013) Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310(19):2050–2060PubMed

166.

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P (2014) Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol 64(21):2222–2231PubMed

Titel: The importance of sleep-disordered breathing in cardiovascular disease
verfasst von: Dominik Linz
Holger Woehrle
Thomas Bitter
Henrik Fox
Martin R. Cowie
Michael Böhm
Olaf Oldenburg
Publikationsdatum: 01.09.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 9/2015
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-015-0859-7

Neu im Fachgebiet Kardiologie

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The importance of sleep-disordered breathing in cardiovascular disease

Abstract

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2015

Tetralogy of Fallot with Holt–Oram syndrome: case report and review

Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study

A patient with a rare cause of elevated troponin I

Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging

Transfemoral TAVI without pre-dilatation using balloon-expandable devices: a case-matched analysis

Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie